PROSABI: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Abiraterone Acetate.
Clinical trial NCT02787837 · UNKNOWN
Trial details
- NCT number
- NCT02787837
- Sponsor
- Centro Nacional de Investigaciones Oncologicas CARLOS III
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2014-05-01
- Primary completion
- 2018-04-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.